Journals / Retina-Vitreus / 2016 / Cilt: 24 - Sayı: 1

GÜNCEL KONU/QUEST EDITORIALS

Diyabetik Retinopati ve Mikronütrisyon

Pages
1–6
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the role of free radicals and antioxidants in diabetic retinopathy is discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetic retinopathy is the major ocular complication associated with diabetes.
📊
Key Findings & Data:Metabolic stresss which plays a role in the diabetic retinopathy increases the oxidative stress then vascular damage is formed.
💡
Conclusion & Impact:In this review, the role of free radicals and antioxidants in diabetic retinopathy is discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diabetic retinopathy is the major ocular complication associated with diabetes. It is the leading cause of legal blindness in the working-age population of developed countries. Control of hyperglisemia, blood pressure and serum lipid levels can prevent diabetic retinopathy onset and progression. However well diabetes control does not eliminate the potential for vision complications. Metabolic stresss which plays a role in the diabetic retinopathy increases the oxidative stress then vascular damage is formed. The degree of tissue damage depends on the balance between the antioxidant defance system and free radicals. In this review, the role of free radicals and antioxidants in diabetic retinopathy is discussed.

Özet

Diyabetik retinopati, diyabetin en sık görülen göz komplikasyonlarından biridir. Gelişmiş ülkelerde çalışan yaş grubunda en önemli legal körlük nedenidir. Hiperglisemi, kan basıncı ve serum lipit seviyelerinin kontrolü diyabetik retinopatinin başlamasını ve ilerlemesini geciktirebilmektedir. Ancak iyi bir diyabet kontrolüne rağmen görme ile ilgili potansiyel komplikasyonlar ortadan kaldırılamamaktadır. Diyabetik retinopati patogenezinde rol oynayan metabolik stres, oksidatif stresin dolayısıyla vasküler hasarın artmasına yol açmaktadır. Doku hasarının derecesi ise serbest radikaller ile antioksidan koruyucu sistem arasındaki dengeye bağlıdır. Bu derlemede diyabetik retinopati patogenezinde serbest radikallerin ve antioksidanların yeri literatür taramasıyla irdelenmiştir.

🔖

Cite This Article

UZUNOVALI, B., ÖNER, A. Ö. (2016). GÜNCEL KONU/QUEST EDITORIALS. Retina-Vitreus, Cilt: 24 - Sayı: 1, 1–6. https://ajindex.com/articles/307997

References (8)

  1. Gren DR, Amarante-Mendes GP. The point of no return: mitokondria, caspases and the commitment to celll death. Result probl cell differ. 1998;24:45-61.
  2. Liu CY, Lee CF, Wei YH. Role of reactive oxygen species-elicited apop- tosis in the pathophysiology of mitokondrial and neurodegenerative diseases associated with mitochondrial DNA mutations. J Formos Med Assoc 2009;108:599-611.
  3. Engerman RL, Kern TS. Diabetic retinopathy: is it a consequence of hyperglycemia. Diabet Med 1985;2:200-203. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complication Research Group. Effect of intensive therapy on the mikrovascular complicationsof tip I diabetes mellitus. JAMA 2002;287:2563-9. Fowler MJ. Mikrovascular and macrovasküler complications of diabe- tes. Clin Diabets 2008;26:77-82.
  4. Kumari S, Panda S, Mangaraj M, et al. Plasma MDA and antioxi- dant vitamins in diabetic retinopathy. Indian J Clin Biochemistery 2008;23:158-62. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glu- cose control with sulfonylureas or insulin compared with conventional treatment and risk of comlications in patients with type 2 diabetes. Lancet 1998;352:854-65. Browlee M. The pathobiology of diabetic complications:a unifying mec- hanism. Diabetes 2005;54:1615-25. The Diabetes Control and Complication Group. The effect of intensive treatment of diabetes on the development of progression of long-term complications in insulin-dependent diabetes mellitus. The New Eng- land J Med 1993;329:977-86. The Diabetes Control and Complication Trial/Epidemiology of Diabe- tes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type I diabetes four years after a trial of intensive therapy. The New England J Med 2003;342:381-9.
  5. Barnett PA, Gonzales RG, Chylack LT, et al. The effect of oxidation on sorbitol pathway kinetics. Diabetes 1986;35:426-32.
  6. Ganz MB, Seftel A. Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am J Physiology-Endocrino- logy and Metabolism 2000;278:146-52.
  7. Yung S, Chau MKM, Zhang Q, et al. Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with strep- tozocin-induced type I diabetic nephropthy. Plos One 2013;8(1)e54501. Ha H, Mi RY, Yoon JC, et al. Role of high glucose-ınduced nuclear factor-kB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Sci Nephrology 2002;13:894-902.
  8. Kolm-Litty V, S